Jul 15, 2022 4:05pm EDT NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022
Jun 21, 2022 2:00am EDT NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer
Jun 03, 2022 4:05pm EDT NeoGenomics To Participate In Multiple Upcoming Institutional Investor Conferences